Detalhe da pesquisa
1.
Tyrosine kinase inhibitor-induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors.
Blood
; 132(1): 67-77, 2018 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29784639
2.
Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms.
Blood
; 130(26): 2848-2859, 2017 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29042365
3.
Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells.
Cell Rep
; 23(11): 3127-3136, 2018 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29898385
4.
Effect of Quadrivalent Human Papillomavirus Vaccination on Oral Squamous Cell Papillomas.
JAMA Dermatol
; 151(12): 1359-1363, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26332141
5.
Dermatofibrosarcoma protuberans (DFSP) with fibrosarcomatous changes in a patient with psoriasis treated with adalimumab.
JAAD Case Rep
; 1(5): 272-273, 2015 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26645047